Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cystex Liquid Cranberry Complex is an oral liquid dietary supplement marketed under the Cystex brand to support urinary tract health and help reduce the risk of recurrent urinary tract infections. It is a multi-ingredient nutraceutical formulation containing cranberry concentrate, d-mannose, vitamin C, fructo-oligosaccharides, and bromelain. Rather than acting as a regulated pharmaceutical with a defined molecular target, the product is positioned as a urinary health maintenance supplement whose intended effects are based on supportive anti-adhesion, urinary milieu, prebiotic, and general wellness mechanisms commonly attributed to its ingredients. It is supplied as a 7.6 oz liquid bottle, typically dosed as 15 mL once daily, and is marketed as lactose-free, gluten-free, and low-calorie. As a dietary supplement, it is not intended to diagnose, treat, cure, or prevent disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Cystex Liquid Cranberry Complex.